new version V2017

     

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

atrial fibrillation

ANTIPAF ongoing olmesartanplacebo Low risk of bias - NCT00098137

diabetes type 2

ORIENTolmesartanplaceboNegativeNCT00141453
ROADMAP, 2010olmesartanplacebo Low risk of bias Suggesting NCT00185159

diabetic kidney disease

ORIENTolmesartanplaceboNegativeNCT00141453

miscellaneous

ORIENTolmesartanplaceboNegativeNCT00141453
ROADMAP, 2010olmesartanplacebo Low risk of bias Suggesting NCT00185159